Ingen internetforbindelse — viser den gemte version af siden.

メディシノバ・インク

MediciNova IncUSUSD
← Til Screeneren

MediciNova Inc (TSE:4875) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
medicinova.com
Investorrelationer
medicinova.com/ir/
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
LA JOLLA, United States
Administrerende Direktør
Yuichi Iwaki
Ansatte
6
Børsnoteret Siden
04.10.2026 (TSE:4875, på børsens liste i vores database)
Udestående Aktier
49.22 mio. pr. 2026-10-09
DatoAktierÆndring
09.10.202649.22 mio.—ingen væsentlige ændringer
08.10.202649.22 mio.—ingen væsentlige ændringer
02.10.202649.22 mio.—ingen væsentlige ændringer
11.08.202649.22 mio.
Antal aktier ifølge virksomhedens rapporter. Et aktiesplit registreres ved et spring i antallet med et helt multiplum.
Free Float
42.94 mio.
Markedsværdi
74.82 mio. USD
Insidere
2.86%
Institutionelle Investorer
20.38%
Branche (SIC)
Pharmaceutical Preparations
FCF
−9.12 mio. USD
Gæld
0 USD
nettokasse
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksMNOV primærUSD1.54 -4.35%almindelige aktier
TSE Tokyo Stock Exchange4875 sekundærJPY245 +1.66%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs
annonce

Største Ejere

EjerAndelAktierRapportdato
Essex Woodlands Manageme…2.25%1.11 mio.2026-06-30
Blackrock Inc.1.53%752 0912026-06-30
Citigroup Inc.1.29%635 7152026-06-30
Vanguard Capital Managem…1.24%609 0522026-06-30
VANGUARD INDEX FUNDS-Van…1.24%609 0522026-06-30
Geode Capital Management…1.1%539 3122026-06-30
Vanguard Fiduciary Trust…0.57%282 6082026-06-30
Fidelity Concord Street…0.51%251 2052026-07-31
UBS Group AG0.45%222 2002026-06-30
Renaissance Technologies…0.42%205 4002026-06-30
State Street Corporation0.39%193 6982026-06-30
iShares Trust-iShares Mi…0.32%157 9302026-08-31
Northern Trust Corporati…0.29%143 6652026-06-30
Fidelity Concord Street…0.18%87 5752026-07-31
SCHWAB CAPITAL TRUST-Sch…0.15%71 5062026-07-31
Fidelity Concord Street…0.14%68 4062026-07-31
Fidelity Concord Street…0.05%24 5332026-07-31
Northern Funds-SMALL CAP…0.03%13 8942026-06-30
EQ Advisors Trust-1290 V…0.02%10 5252026-06-30
LINCOLN Varbl INSURANCE…0.01%6 6932026-06-30
3D INVESTMENT PARTNERS P…——2026-09-25